ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $17.3K in total
- 1
- 13F holdersQ2 2026, −4 vs. previous quarter
- 35
- 13F valueReported value at the end of Q2 2026
- $36.8M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding IMA, Q2 2026
No superinvestor reported holding IMA at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by ImageneBio, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2026 (view filing)9:47 PM ET | Jul 16-17 | 4 days | Lally Robert BPrincipal Accounting Officer | SSale | −3.20K | $5.42 | −$17.3K | −5.4%55.6K after | 2 lots |
| Apr 16, 2026 (view filing)7:23 PM ET | Apr 14 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | PPurchase | +721.3K | – | – | –384.7K after | Derivative2 lotsDuplicate filing |
| Apr 16, 2026 (view filing) | Apr 14 | 2 days | Bonita David PDirector | PPurchase | +721.3K | – | – | –384.7K after | Derivative2 lots |
| Dec 29, 2025 (view filing) | Dec 24 | 5 days | Slattery Joseph PDirector | PPurchase | +16.0K | $5.99 | +$95.8K | New position16.0K after | |
| Jul 30, 2025 (view filing) | Jul 25 | 5 daysLate | Bonita David PDirector | PPurchase | +83.6K | $29.90 | +$2.50M | +40.9%287.9K after | |
| Jul 30, 2025 (view filing) | Jul 25 | 5 daysLate | Stampacchia OtelloDirector | PPurchase | +267.6K | $29.90 | +$8.00M | +142.8%455.0K after | |
| Jun 24, 2022 (view filing)5:39 PM ET | Jun 22-24 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | PPurchase | −252.2K | $4.47 | −$1.13M | −10.7%2.10M after | 4 lotsDuplicate filing |
| Jun 24, 2022 (view filing) | Jun 22-24 | 2 days | Bonita David PDirector | PPurchase | −252.2K | $4.47 | −$1.13M | −10.7%2.10M after | 4 lots |
| Jan 12, 2022 (view filing) | Jan 10-11 | 2 days | Zhang Xiaoyan MichelleChief Scientific Officer | SSale | −1.00K | $12.00 | −$12.0K | −2.2%44.5K after | 2 lots |
| Dec 14, 2021 (view filing)8:27 PM ET | Mar 30 | 259 daysLate | Atlas Venture Fund XI, L.P. and 5 others10% Owner | PPurchase | +125.0K | $16.00 | +$2.00M | +16.7%874.6K after | Duplicate filing |
Top 10 13F holders, Q2 2026
The largest institutional positions in ImageneBio, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 1,110,002 | $6.55M | 0.17% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 917,692 | $5.41M | 0.82% | −41,645−4.3% | Reduced |
| OrbiMed Advisors LLC | 909,269 | $5.36M | 0.10% | +530,713+140.2% | Added |
| Cable Car Capital LLC | 781,599 | $4.61M | 0.10% | +26,850+3.6% | Added |
| Omega Fund Management, LLC | 455,361 | $2.69M | 1.45% | 00.0% | Unchanged |
| RTW Investments, LP | 334,445 | $1.97M | 0.02% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 320,518 | $1.89M | 0.00% | −4,637−1.4% | Reduced |
| Trails Edge Capital Partners, LP | 282,004 | $1.66M | 0.26% | +282,004 | New |
| BML Capital Management, LLC | 200,730 | $1.18M | 0.68% | 00.0% | Unchanged |
| Monashee Investment Management LLC | 192,344 | $1.13M | 1.90% | +192,344 | New |